Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cosmo Pharmaceuticals N.V.
  6. News
  7. Summary
    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
Delayed Swiss Exchange  -  11:30 2022-06-24 am EDT
46.00 CHF   -0.54%
06/21COSMO PHARMACEUTICALS N : June Investor Presentation
PU
06/01COSMO PHARMACEUTICALS N.V. : Ex-dividend day for final dividend
FA
05/27COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual General Meeting
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cosmo Pharmaceuticals, Medtronic Sign Global Distribution Deal for Eleview

05/03/2022 | 01:25am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
COSMO PHARMACEUTICALS N.V. -0.54% 46 Delayed Quote.-29.50%
MEDTRONIC PLC 1.75% 90.22 Delayed Quote.-12.79%
All news about COSMO PHARMACEUTICALS N.V.
06/21COSMO PHARMACEUTICALS N : June Investor Presentation
PU
06/01COSMO PHARMACEUTICALS N.V. : Ex-dividend day for final dividend
FA
05/27COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual General Meetin..
PU
05/27Cosmo Pharmaceuticals? Shareholders approve all Agenda Items at Annual General Meeting ..
EQ
05/25COSMO PHARMACEUTICALS N : May Investor Presentation
PU
05/03Cosmo Pharmaceuticals, Medtronic Sign Global Distribution Deal for Eleview
MT
05/03Cosmo announces expanding the agreement with medtronic for eleview(r) to all countries ..
EQ
05/03Cosmo Pharmaceuticals N.V. Announces Expanding the Agreement with Medtronic for Eleview..
CI
05/03COSMO PHARMACEUTICALS N : Announces expanding the agreement with medtronic for eleview® to..
PU
05/02COSMO PHARMACEUTICALS N : Notification of number of shares
PU
More news
Analyst Recommendations on COSMO PHARMACEUTICALS N.V.
More recommendations
Financials
Sales 2022 96,7 M 102 M 102 M
Net income 2022 16,8 M 17,7 M 17,7 M
Net cash 2022 41,8 M 44,1 M 44,1 M
P/E ratio 2022 45,9x
Yield 2022 1,31%
Capitalization 763 M 805 M 805 M
EV / Sales 2022 7,46x
EV / Sales 2023 5,13x
Nbr of Employees 290
Free-Float 48,0%
Chart COSMO PHARMACEUTICALS N.V.
Duration : Period :
Cosmo Pharmaceuticals N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMO PHARMACEUTICALS N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 45,68 €
Average target price 85,12 €
Spread / Average Target 86,3%
EPS Revisions
Managers and Directors
Alessandro Della Chà Executive Director
Niall Donnelly Chief Financial Officer
Mauro Severino Ajani Director
Davide Malavasi Director-Qualified Person & Technical
Nhan Ngo Dinh Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
COSMO PHARMACEUTICALS N.V.-29.50%766
JOHNSON & JOHNSON5.02%462 443
ELI LILLY AND COMPANY17.88%276 070
PFIZER, INC.-15.17%275 327
ABBVIE INC.12.51%260 755
ROCHE HOLDING AG-19.20%259 627